US 8057807
Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
granted A61KA61K31/16A61K31/353
Quick answer
US patent 8057807 (Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/16, A61K31/353, A61K38/4893, A61P